Prostate cancer is the most common cancer among men in 112 countries worldwide. However, if prostate cancer is detected early enough, the chances of recovery are very high. This requires that the disease be detected early enough using meaningful biomarkers. Dr. Maximilian Lindholz and Dr. Charlie…
The new software tool ovrlpy improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international collaboration, ovrlpy is the first tool to identify cell overlaps and folds in tissue sections,…
The liver plays a central role in the body’s metabolism and immune regulation. Yet, many cellular mechanisms involved in liver diseases remain only partially understood. Researchers from Charité, Si-M – The Simulated Human and the Cincinnati Children’s Hospital Medical Center have now gained crucial…
Charité – Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH), and Enterprise Singapore (ESG) are continuing their successful international collaboration. In November 2025, the Memorandum of Understanding (MoU) underpinning their joint co-innovation programme was renewed for…
The Berlin Institute of Health at Charité (BIH) is strengthening its research faculty in February with the appointments of Dr. Leif Si-Hun Ludwig and Dr. Daniel Ortmann. Ludwig has been awarded a prestigious Heisenberg professorship in stem cell dynamics and mitochondrial genomics, a position funded…
A person's metabolism is as unique as their fingerprint, and so is their risk of developing certain diseases. A better understanding of the genetic influences on metabolism could open up new therapeutic options. Researchers at the Berlin Institute of Health at Charité (BIH) and Queen Mary University…
The Berlin Institute of Health at Charité (BIH) is coordinating the central European research project "EU-CiP" (European Cancer Information Portal). This project is funded with 12 million euros over four years by the European Union's Horizon Europe program. For the first time, it establishes a…
Digitalisation can fundamentally change healthcare: faster processes, better data availability and more time for patients. But despite the technical possibilities, there are obstacles that slow down progress. How can digitalisation be designed in such a way that it does not remain a technological…
The Berlin Institute of Health at Charité (BIH) and ProBioGen today announced a major collaboration to manufacture materials for gene and cell therapies. The partnership was unveiled at the groundbreaking ceremony for the Berlin Center for Gene and Cell Therapies (BC GCT), which features a 4,600 m²…
